Infervision, a Chinese startup that offers artificial intelligence (AI)-based medical imaging solutions, has closed a new investment that brings the firm’s total capital raise in its Series D round to nearly 900 million yuan ($139 million).
Infervision is a Pennsylvania-based health-tech platform that solutions such as AI-powered medical imaging and disease screening for the healthcare industry.